Bettendorf Healthplex Lab

Summary Statement of Deficiencies D0000 A proficiency testing desk review survey was completed on August 6, 2026. The laboratory was found to be out of compliance with the following CONDITION LEVEL DEFICIENCIES: D2016 - 42 C.F.R 493.803 Condition: Successful Participation D6000 - 42 C.F.R 493.1403 Condition: Laboratory Director, moderate complexity D2016 SUCCESSFUL PARTICIPATION CFR(s): 493.803(a)(b)(c) (a) Each laboratory performing nonwaived testing must successfully participate in a proficiency testing program approved by CMS, if applicable, as described in subpart I of this part for each specialty, subspecialty, and analyte or test in which the laboratory is certified under CLIA. (b) Except as specified in paragraph (c) of this section, if a laboratory fails to participate successfully in proficiency testing for a given specialty, subspecialty, analyte or test, as defined in this section, or fails to take remedial action when an individual fails gynecologic cytology, CMS imposes sanctions, as specified in subpart R of this part. (c) If a laboratory fails to perform successfully in a CMS- approved proficiency testing program, for the initial unsuccessful performance, CMS may direct the laboratory to undertake training of its personnel or to obtain technical assistance, or both, rather than imposing alternative or principle sanctions except when one or more of the following conditions exists: (1) There is immediate jeopardy to patient health and safety. (2) The laboratory fails to provide CMS or a CMS agent with satisfactory evidence that it has taken steps to correct the problem identified by the unsuccessful proficiency testing performance. (3) The laboratory has a poor compliance history. This CONDITION is not met as evidenced by: Based on review of the Certification and Survey Provider Enhanced Reporting (CASPER) 155 report and graded results from the American Proficiency Institute, the laboratory failed to successfully participate in two out of three consecutive testing Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- events for the analyte, chloride. The laboratory had unsatisfactory scores for 2025 event 3 and 2026 event 2. Refer to D2096. D2096 ROUTINE CHEMISTRY CFR(s): 493.841(f) (f) Failure to achieve satisfactory performance for the same analyte or test in two consecutive testing events or two out of three consecutive testing events is unsuccessful performance. This STANDARD is not met as evidenced by: Based on review of the Certification and Survey Provider Enhanced Reporting (CASPER) 155 report and graded results from the American Proficiency Institute (API), the laboratory failed to successfully participate in two out of three consecutive testing events for the analyte, chloride. The findings include: 1. For 2025 event 3, the laboratory received an unsatisfactory performance score of 60% for the analyte, chloride. 2. For 2026 event 2, the laboratory received an unsatisfactory performance score of 20% for the analyte, chloride. 3. The CASPER 155 report and graded results from API confirm the findings listed above. D6000 MODERATE COMPLEXITY LABORATORY DIRECTOR CFR(s): 493.1403 The laboratory must have a director who meets the qualification requirements of 493. 1405 of this subpart and provides overall management and direction in accordance with 493.1407 of this subpart. This CONDITION is not met as evidenced by: Based on review of the Certification and Survey Provider Enhanced Reporting (CASPER) 155 report and graded results from the American Proficiency Institute (2025 event 3 and 2026 event 2), the laboratory director failed to provide overall management and direction of the laboratory services. Refer to D6016. D6016 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(4)(i) (e)(4)(i) The proficiency testing samples are tested as required under Subpart H of this part; This STANDARD is not met as evidenced by: Based on review of the Certification and Survey Provider Enhanced Reporting (CASPER) 155 report and graded results from the American Proficiency Institute (API), the laboratory director failed to ensure successful participation in an HHS approved proficiency testing program. Refer to D2096. -- 2 of 2 --

Summary Statement of Deficiencies D2000 ENROLLMENT AND TESTING OF SAMPLES CFR(s): 493.801 Each laboratory must enroll in a proficiency testing (PT) program that meets the criteria in subpart I of this part and is approved by HHS. The laboratory must enroll in an approved program or programs for each of the specialties and subspecialties for which it seeks certification. The laboratory must test the samples in the same manner as patients' specimens. For laboratories subject to 42 CFR part 493 published on March 14, 1990 (55 FR 9538) prior to September 1, 1992, the rules of this subpart are effective on September 1, 1992. For all other laboratories, the rules of this subpart are effective January 1, 1994. This CONDITION is not met as evidenced by: Based on review of the Laboratory Test List and Annual Volume form, proficiency testing records, and confirmed by laboratory personnel identifier #2 (refer to the Laboratory Personnel Report) at 10:55 am on 11/21/2023, the laboratory failed to enroll in an approved proficiency testing (PT) program for the analytes, pH, partial pressure of oxygen (PO2), and partial pressure of carbon dioxide (PCO2), for one out of one year in 2023. The findings include: 1. The laboratory began performing arterial and venous blood gas testing including the analytes, pH, PO2, and PCO2, in December 2022. 2. At the time of the survey, personnel identifier #2 confirmed that the laboratory did not enroll in PT for the analytes, pH, PO2, and PCO2, in 2023. D5421 ESTABLISHMENT AND VERIFICATION OF PERFORMANCE CFR(s): 493.1253(b)(1) Each laboratory that introduces an unmodified, FDA-cleared or approved test system must do the following before reporting patient test results: (1)(i) Demonstrate that it can obtain performance specifications comparable to those established by the manufacturer for the following performance characteristics: (1)(i)(A) Accuracy. (1)(i) Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 3 -- (B) Precision. (1)(i)(C) Reportable range of test results for the test system. (1)(ii) Verify that the manufacturer's reference intervals (normal values) are appropriate for the laboratory's patient population. This STANDARD is not met as evidenced by: Based on lack of performance specification records and confirmed by Laboratory Personnel identifier #2 (refer to the Laboratory Personnel Report) at 1:30 pm on 11/21 /2023, the laboratory failed to verify the performance specifications of accuracy and precision for the following test systems: Rh factor, QuickVue serum human chorionic gonadotropin (HCG) qualitative, and K-check ketone. The findings include: 1. The laboratory began using the Rh factor, QuickVue serum HCG qualitative, and K-check ketone test systems in December 2022. 2. At the time of the survey, the laboratory did not have performance specification records for the Rh factor, QuickVue serum HCG qualitative, and K-check ketone test systems. D5445 CONTROL PROCEDURES CFR(s): 493.1256(d)(1)(2)(g) Unless CMS Approves a procedure, specified in Appendix C of the State Operations Manual (CMS Pub. 7), that provides equivalent quality testing, the laboratory must-- (d)(1) Perform control procedures as defined in this section unless otherwise specified in the additional specialty and subspecialty requirements at 493.1261 through 493.1278. (d)(2) For each test system, perform control procedures using the number and frequency specified by the manufacturer or established by the laboratory when they meet or exceed the requirements in paragraph (d)(3) of this section. (g) The laboratory must document all control procedures performed. This STANDARD is not met as evidenced by: A. Based on lack of Individualized Quality Control Plan (IQCP) records, review of quality control (QC) records, and confirmed by laboratory personnel identifier #2 (refer to the Laboratory Personnel Report) at 1:00 pm on 11/21/2023, the laboratory failed to perform two levels of quality control each day of patient testing for the Abbott iStat test system. The findings include: 1. The laboratory performed arterial and venous blood gas testing on two Abbott iStat test systems. 2. The laboratory performed controls with each new lot and shipment of test cartridges and monthly for the Abbott iStat test systems. 3. Laboratory personnel identifier #2 indicated that the laboratory intended to follow the manufacturer's instructions for performing QC. 4. At the time of the survey, the laboratory did not have an IQCP for the Abbott iStat test systems. B. Based on lack of Individualized Quality Control Plan (IQCP) records, review of quality control (QC) records, and confirmed by laboratory personnel identifier #2 (refer to the Laboratory Personnel Report) at 1:30 pm on 11/21/2023, the laboratory failed to perform a positive and negative control each day of patient testing for the QuickVue serum human chorionic gonadotropin (HCG) qualitative test system. The findings include: 1. The laboratory performed controls with each new lot and shipment of test kits for the QuickVue serum HCG qualitative test system. 2. Laboratory personnel identifier #2 indicated that the laboratory intended to follow the manufacturer's instructions for performing QC. 3. At the time of the survey, the laboratory did not have an IQCP for the QuickVue serum HCG qualitative test system. D5775 COMPARISON OF TEST RESULTS -- 2 of 3 -- CFR(s): 493.1281(a)(c) (a) If a laboratory performs the same test using different methodologies or instruments, or performs the same test at multiple testing sites, the laboratory must have a system that twice a year evaluates and defines the relationship between test results using the different methodologies, instruments, or testing sites. (c) The laboratory must document all test result comparison activities. This STANDARD is not met as evidenced by: Based on review of the Laboratory Test List & Annual Volume form, lack of comparison activity records, observation during the survey, and confirmed by laboratory personnel identifier #2 (refer to the Laboratory Personnel Report) at 1:00 pm on 11/21/2023, the laboratory failed to perform and document comparison activities twice annually between two out of two iStat test systems for the analytes: partial pressure of oxygen (PO2), partial pressure of carbon dioxide (PCO2), and pH, for two out of two time periods from 01/01/2023 - 11/21/2023. The findings include: 1. The Laboratory Test List & Annual Volume form listed the laboratory as performing arterial and venous blood gas testing including the analytes, PO2, PCO2, and pH, on the i-STAT test system. 2. An observation made during the survey indicated that the laboratory has two iStat test systems in use. 3. At the time of the survey, personnel identifier #2 confirmed that the laboratory did not perform and document comparison studies between the two iStat test systems from 01/01/2023 - 11 /21/2023. -- 3 of 3 --

Summary Statement of Deficiencies No Tags No deficiency details available. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --